Farther Finance Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.76K | Buy |
411
+99
| +32% | +$1.15K | ﹤0.01% | 3368 |
|
|
2025
Q1 | $2.71K | Buy |
312
+54
| +21% | +$468 | ﹤0.01% | 3270 |
|
|
2024
Q4 | $3.71K | Sell |
258
-173
| -40% | -$2.48K | ﹤0.01% | 2784 |
|
|
2024
Q3 | $9.73K | Buy |
431
+92
| +27% | +$2.08K | ﹤0.01% | 2379 |
|
|
2024
Q2 | $6.3K | Sell |
339
-29
| -8% | -$539 | ﹤0.01% | 2284 |
|
|
2024
Q1 | $13.6K | Buy |
368
+242
| +192% | +$8.97K | ﹤0.01% | 1630 |
|
|
2023
Q4 | $7.05K | Buy |
126
+33
| +35% | +$1.85K | ﹤0.01% | 1791 |
|
|
2023
Q3 | $3.84K | Buy |
93
+40
| +75% | +$1.65K | ﹤0.01% | 1606 |
|
|
2023
Q2 | $2.96K | Sell |
53
-994
| -95% | -$55.5K | ﹤0.01% | 1618 |
|
|
2023
Q1 | $58.4K | Buy |
+1,047
| New | +$58.4K | 0.02% | 563 |
|